New hemophilia drug aims for Long-Term bleeding control

NCT ID NCT03754790

Summary

This study is checking the long-term safety and effectiveness of a drug called fitusiran for people with severe hemophilia A or B. It involves about 281 male participants, aged 12 and older, who have already been in a previous fitusiran trial. The main goal is to see how well the drug controls bleeding episodes over many years and to monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Alliance for Childhood Diseases Site Number : 8400007

    Las Vegas, Nevada, 89135-3011, United States

  • Center for Inherited Blood Disorders (CIBD) Site Number : 8400016

    Orange, California, 92868, United States

  • Children's Hospital Los Angeles Site Number : 8400019

    Los Angeles, California, 90027, United States

  • Childrens Hospital Medical Center of Akron Site Number : 8400006

    Akron, Ohio, 44308, United States

  • Investigational Site Number : 0360001

    Camperdown, New South Wales, 2050, Australia

  • Investigational Site Number : 0360002

    Murdoch, Western Australia, 6961, Australia

  • Investigational Site Number : 0360003

    Prahran, Victoria, 3181, Australia

  • Investigational Site Number : 1240001

    Montreal, Quebec, H1T 2M4, Canada

  • Investigational Site Number : 1560002

    Guangzhou, 510515, China

  • Investigational Site Number : 1560003

    Shanghai, 200025, China

  • Investigational Site Number : 1560004

    Beijing, 100045, China

  • Investigational Site Number : 1560005

    Hangzhou, 89147, China

  • Investigational Site Number : 1560006

    Suzhou, 215006, China

  • Investigational Site Number : 1560007

    Beijing, 100730, China

  • Investigational Site Number : 1560008

    Jinan, 250013, China

  • Investigational Site Number : 1560009

    Chengdu, 610091, China

  • Investigational Site Number : 1560010

    Qingdao, 266555, China

  • Investigational Site Number : 1560011

    Guiyang, 550004, China

  • Investigational Site Number : 1560012

    Kunming, 650000, China

  • Investigational Site Number : 1560013

    Lanzhou, 730000, China

  • Investigational Site Number : 1560014

    Changsha, 410008, China

  • Investigational Site Number : 1580001

    Taipei, 110, Taiwan

  • Investigational Site Number : 1580002

    Changhua, 500, Taiwan

  • Investigational Site Number : 1580003

    Taipei, 100, Taiwan

  • Investigational Site Number : 1580004

    Taichung, 40705, Taiwan

  • Investigational Site Number : 1580005

    Taipei, 112, Taiwan

  • Investigational Site Number : 1580007

    Taoyuan, 33305, Taiwan

  • Investigational Site Number : 1580008

    Taichung, 40201, Taiwan

  • Investigational Site Number : 2080001

    Copenhagen, 2100, Denmark

  • Investigational Site Number : 2500002

    Lyon, 69677, France

  • Investigational Site Number : 2500003

    Paris, 75015, France

  • Investigational Site Number : 2760001

    Berlin, 10249, Germany

  • Investigational Site Number : 2760003

    Leipzig, 04103, Germany

  • Investigational Site Number : 3480002

    Budapest, 1134, Hungary

  • Investigational Site Number : 3560001

    Bangalore, 560034, India

  • Investigational Site Number : 3560002

    Pune, 411001, India

  • Investigational Site Number : 3560004

    Ranipet, 632517, India

  • Investigational Site Number : 3560005

    Lucknow, 226003, India

  • Investigational Site Number : 3560007

    Mumbai, 400 022, India

  • Investigational Site Number : 3560010

    Pune, 411004, India

  • Investigational Site Number : 3720001

    Crumlin, Dublin, 12, Ireland

  • Investigational Site Number : 3720002

    Dublin, 8, Ireland

  • Investigational Site Number : 3760001

    Ramat Gan, 5262100, Israel

  • Investigational Site Number : 3800002

    Milan, Lombardy, 20122, Italy

  • Investigational Site Number : 3800004

    Padua, Veneto, 35128, Italy

  • Investigational Site Number : 3920001

    Nagoya, 4668560, Japan

  • Investigational Site Number : 3920002

    Nishinomiya, Hyōgo, 663-8501, Japan

  • Investigational Site Number : 3920003

    Kitakyushu, 8078555, Japan

  • Investigational Site Number : 3920004

    Saitama, 330-8777, Japan

  • Investigational Site Number : 3920005

    Isehara, Kanagawa, 2591193, Japan

  • Investigational Site Number : 3920008

    Tokyo, 1600023, Japan

  • Investigational Site Number : 4100001

    Busan, Busan, 602-739, South Korea

  • Investigational Site Number : 4100002

    Daejeon, Daejeon, 35233, South Korea

  • Investigational Site Number : 4100003

    Seoul, Seoul-teukbyeolsi, 03722, South Korea

  • Investigational Site Number : 4100004

    Seoul, 3722, South Korea

  • Investigational Site Number : 4580001

    Johor Bahru, 80100, Malaysia

  • Investigational Site Number : 4580002

    Kota Kinabalu, 88586, Malaysia

  • Investigational Site Number : 4580003

    Ampang, 68000, Malaysia

  • Investigational Site Number : 7100002

    Port Elizabeth, 6001, South Africa

  • Investigational Site Number : 7920002

    Adana, 01130, Turkey (Türkiye)

  • Investigational Site Number : 7920003

    Izmir, TR-35100, Turkey (Türkiye)

  • Investigational Site Number : 7920004

    Akdeniz, 07059, Turkey (Türkiye)

  • Investigational Site Number : 7920005

    Istanbul, 34093, Turkey (Türkiye)

  • Investigational Site Number : 7920006

    Gaziantep, 27100, Turkey (Türkiye)

  • Investigational Site Number : 7920007

    Samsun, 55200, Turkey (Türkiye)

  • Investigational Site Number : 7920008

    Kayseri, 38039, Turkey (Türkiye)

  • Investigational Site Number : 7920012

    Bornova, 35100, Turkey (Türkiye)

  • Investigational Site Number : 8040001

    Kyiv, 04060, Ukraine

  • Investigational Site Number : 8040002

    Lviv, 79044, Ukraine

  • Investigational Site Number : 8040003

    Kyiv, 1135, Ukraine

  • Investigational Site Number : 8040004

    Mykolaiv, 54058, Ukraine

  • Investigational Site Number : 8260001

    London, London, City of, SE1 9RT, United Kingdom

  • Investigational Site Number : 8260004

    Glasgow, G4 0SF, United Kingdom

  • Nemours Children's Clinic Site Number : 8400008

    Jacksonville, Florida, 32207, United States

  • Phoenix Childrens Hospital Site Number : 8400009

    Phoenix, Arizona, 85016, United States

  • Rush University Medical Center -1725 W Harrison St Site Number : 8400001

    Chicago, Illinois, 60612-3863, United States

  • St Joseph's Children's Hospital of Tampa Site Number : 8400002

    Tampa, Florida, 33607, United States

  • University of Michigan Hospital - 1500 E Medical Center Dr Site Number : 8400012

    Ann Arbor, Michigan, 48109-5000, United States

  • ~Massachusetts General Hospital Site Number : 8400011

    Boston, Massachusetts, 02114, United States

Conditions

Explore the condition pages connected to this study.